Revolution Medicines stock surges over 20% on potential AbbVie acquisition

Go back to Revolution Medicines stock surges over 20% on potential AbbVie acquisition
AbbVie (NYSE: ABBV) Delayed: 261.83 -4.14 (1.56%)
Previous Close $265.97    52 Week High $68.12 
Open $265.69    52 Week Low $50.71 
Day High $265.93    P/E 56.80 
Day Low $260.48    EPS $4.61 
Volume 5,125,683       

(NASDAQ: ERAS) Delayed: 17.08 -0.99 (5.48%)
Previous Close $18.07    52 Week High
Open $17.59    52 Week Low
Day High $17.77    P/E N/A 
Day Low $16.92    EPS
Volume 2,666,409       

(NASDAQ: RVMD) Delayed: 211.74 -2.92 (1.36%)
Previous Close $214.66    52 Week High
Open $212.26    52 Week Low
Day High $213.74    P/E N/A 
Day Low $208.02    EPS
Volume 1,510,786       

(NASDAQ: TNGX) Delayed: 23.51 -1.69 (6.71%)
Previous Close $25.20    52 Week High
Open $25.51    52 Week Low
Day High $25.67    P/E N/A 
Day Low $23.15    EPS
Volume 2,064,609       

VERASTEM SHS (NASDAQ: VSTM) Delayed: 6.82 -0.48 (6.58%)
Previous Close $7.30    52 Week High $2.43 
Open $7.25    52 Week Low $1.05 
Day High $7.43    P/E N/A 
Day Low $6.63    EPS $-1.79 
Volume 2,292,660